Canadian Gold Corp.
Canadian Gold Corp. (CGC.V) Financial Performance & Income Statement Overview
Explore the financials of Canadian Gold Corp. (CGC.V), including yearly and quarterly data on income, cash flow, and balance sheets.
Canadian Gold Corp. (CGC.V) Income Statement & Financial Overview
Analyze Canadian Gold Corp.’s CGC.V earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $2283.00 | $2282.00 | $8077.00 | $2258.00 |
| Gross Profit | -$2283.00 | -$2282.00 | -$8077.00 | -$2258.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $181884.00 | $112892.00 | $301476.00 | $99201.00 |
| Operating Expenses | $949603.00 | $1.16M | $301476.00 | $1.21M |
| Total Costs & Expenses | $951886.00 | $1.16M | -$309553.00 | $1.21M |
| Interest Income | $1115.00 | $28162.00 | $4259.00 | $8080.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2283.00 | $8104.00 | $8077.00 | $2258.00 |
| EBITDA | -$853406.00 | -$1.03M | -$191587.00 | -$1.21M |
| EBITDA Ratio | ||||
| Operating Income | -$951886.00 | -$1.16M | -$309553.00 | -$1.21M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $90375.00 | $123833.00 | $109887.00 | $236332.00 |
| Income Before Tax | -$861511.00 | -$1.04M | -$199666.00 | -$976272.00 |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$861511.00 | -$1.04M | -$199666.00 | -$976272.00 |
| Net Income Ratio | ||||
| EPS | -$0.005 | -$0.01 | -$0.001 | -$0.01 |
| Diluted EPS | -$0.005 | -$0.01 | -$0.001 | -$0.01 |
| Weighted Avg Shares Outstanding | $189.42M | $183.89M | $144.30M | $174.86M |
| Weighted Avg Shares Outstanding (Diluted) | $189.42M | $183.89M | $144.30M | $174.86M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to N/A in Q1 2024. Operating income hit -$951886.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$853406.00. Net income rose to -$861511.00, while earnings per share reached -$0.005. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan